SCHEMBL7058684

SCHEMBL7058684

CC(C)(C)[Si](C)(C)Oc1ccc([C@H]2CC[C@@H](NOC(=O)c3ccccc3)CC2)c(O[Si](C)(C)C(C)(C)C)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
HSP90AA1 P07900 1/20 0.34
HSP90AB1 P08238 1/20 0.34
NPC1 O15118 1/20 0.34
ELANE P08246 1/20 0.33
KMT2A Q03164 4/20 0.33
MAPT P10636 2/20 0.33
ALDH1A1 P00352 1/20 0.33
POLB P06746 1/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA9 Q16790 2/20 0.32
MEN1 O00255 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CCNC P24863 1/20 0.32
CDK8 P49336 1/20 0.32
SSTR1 P30872 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7255762 1.00 KDM4E (0.35) KDM4EHSP90AA1HSP90AB1NPC1ELANE
SCHEMBL7058680 1.00 KDM4E (0.35) KDM4EHSP90AA1HSP90AB1NPC1ELANE
SCHEMBL7063726 0.86 NPC1 (0.47) KDM4ENPC1KMT2AALDH1A1MEN1
SCHEMBL7063724 0.86 NPC1 (0.47) KDM4ENPC1KMT2AALDH1A1MEN1
SCHEMBL7062204 0.82 KDM4E (0.39) KDM4EHSP90AA1HSP90AB1ELANEMAPT
SCHEMBL6435288 0.80 MTNR1A (0.37) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL6433452 0.80 MTNR1A (0.37) HSP90AA1HSP90AB1CA12CA1CA9
SCHEMBL7213965 0.79 CA12 (0.36) HSP90AA1HSP90AB1NPC1CA12CA1
SCHEMBL7063409 0.79 HSP90AA1 (0.35) HSP90AA1HSP90AB1ELANEKMT2ALMNA
SCHEMBL7063406 0.79 HSP90AA1 (0.35) HSP90AA1HSP90AB1ELANEKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6797731-B2 USE AS SKIN LIGHTENING AGENTS PFIZER INC. 2004-09-28 US disclosed
US-20030190298-A1 Resorcinol derivatives BRADLEY STUART E (GB) 2003-10-09 US disclosed
US-6541473-B2 Use as skin lightening agents; 4-(1,4-Dioxaspiro(4.5)dec-8-yl)-1,3-benzenediol for example WARNER LAMBERT COMPANY 2003-04-01 US disclosed
US-20020137961-A1 Resorcinol derivatives PFIZER INC. 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030190298-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 KDM4E 2885/4885HSP90AA1 1266/4885HSP90AB1 1208/4885
US-20020137961-A1 Resorcinol derivatives LRAT, NQO1, ALDH1A2 KDM4E 2885/4885HSP90AA1 1266/4885HSP90AB1 1208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.